| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |